Founded in 2010, Yili Chuanning Biotechnology Co., Ltd. is a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd., specializing in the R&D and industrialization of biological fermentation technology. The company’s primary products include erythromycin thiocyanate, cephalosporin intermediates, Penicillin G Potassium, and Ursodeoxycholic Acid. It is located in the Khorgos Economic Development Zone, Xinjiang, and plays a significant role in China’s antibiotic production industry.